Home > Researchers > Atsushi Fukuda
Japanese Page
　

Atsushi Fukuda　Junior Associate Professor

 

Affiliation

School of Medicine, Faculty of Medicine, Basic Medical Science and Molecular Medicine
Institute of Medical Science

Contact

E-mail : fa972942[at]tsc.u-tokai.ac.jp

Degree/ License

Ph.D.

Biography

2012
Ph.D. Graduate School of Tokyo University of Agriculture.
2012—2016
National Research Center for Child Health and Development. Center for Regenerative Medicine. Researcher
2016—2017
National Research Center for Child Health and Development. Center for Regenerative Medicine. Senior Researcher
2017—2019
Department of Stem Cell and Regenerative Biology. Harvard University. (Kevin Eggan lab) (JSPS Postdoctoral Fellowships for Research Abroad)
2019～2020
Institute of Innovative Science and Technology, Tokai University; Assistant Professor
2020～2021
Institute of Medical Science, Tokai University; Junior Associate Professor
2021～
Tokai Unibersity
School of Medicine, Faculty of Medicine, Basic Medical Science and Molecular Medicine
(Junior Associate Professor, Ministry of Education Excellent Young Researcher)

Research Field

Using human ES/iPS cells, our laboratory conducts basic research for neuronal disease modeling and translational research based on transcription and epigenomic states. In particular, through X chromosome inactivation, which is the representative epigenomic event in women, we try to understand the differentiation propensity based on sex and the X-linked disease. We also use genome editing and next generation sequence technologies to accomplish functional and molecular analysis.

Keywords

Human pluripotent stem cell, Epigenetics, Sex difference, Genome editing, Neuronal differentiation

Membership (of Academic Organization)

  • The society for molecular biology

Honors

  • The society for Reproduction and Development 2012 (Best presentation)
  • Reproduction Prize 2017 (Best paper in 2016)

Message

We are very welcome for people who has interests in molecular mechanisms underlying neuronal disease and in epigenetic research using human ES/iPS cells.